Completed PHASE4 INTERVENTIONAL 4-arm NCT00957801

Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men

Sponsor: The University of Texas Medical Branch, Galveston

Interventions Medrol Testosterone gel Testosterone injection

Updated 7 times since 2017 Last updated: Apr 4, 2018 Started: Mar 31, 2009 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Sarcopenia and is currently completed. The University of Texas Medical Branch, Galveston leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
May 2018 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — May 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Texas Medical Branch, Galveston

Data source: The University of Texas Medical Branch, Galveston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Galveston, United States